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ABSTRACT
The umbilical cord is seen as the main junction between the developing 
embryo or fetus and placenta. We studied the antimicrobial response, the pres-
ence of undifferentiated cells and TGF-α, as well as tissue degeneration and 
compensatory remodelling processes in the cells of human umbilical cord.
Seven umbilical cord tissue samples obtained during premature and full 
term births were stained with hematoxylin and eosin and by immunohisto-
chemistry for human beta defensin 2 (hBD-2), hematopoietic progenitor cell 
antigen CD34, matrix metalloproteinase 2 (MMP-2), the tissue inhibitor of 
matrix metalloproteinase 2 (TIMP-2), nestin and transforming growth factor 
alpha (TGF-α). The intensity of staining was graded semiquantitatively.
Antimicrobial response was more prominent in the Wharton’s jelly – we 
found numerous hBD-2-containing cells, while hBD-2 positive cells in the 
walls of arteries and vein varied from moderate to abundance. Numerous cells 
in the Wharton’s jelly contained CD34, while in the walls of blood vessels few 
to moderate stained positive for CD34. MMP-2, TIMP-2 and nestin positive 
cells were found in all the tissue samples and varied from numerous in the 
walls of blood vessels to abundance in the Wharton’s jelly and the inflamma-
tion region. The abundance of TGF-α-containing cells was found in Wharton’s 
jelly and moderate to numerous cells of blood vessels contained TGF-α. 
Conclusions: The human umbilical cord possesses antimicrobial activity 
and shows the presence of undifferentiated cells. The striking distribution and 
the expression of MMP-2, TIMP-2 and nestin suggest their role in the very 
effective and extensive tissue degeneration and compensatory remodelling 
processes. TGF-α seems to be an important growth factor for extra-embryonic 
tissue development.
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INTRODUCTION
Umbilical cord is seen as the main junction between the developing embryo or 
fetus and placenta. At the same time the human umbilical cord tissue should 
also be considered as a possible extensive source of mesenchymal stem cells. 
Th e mesenchymal stem cells derived from the Wharton’s jelly of the human 
umbilical cord have been isolated with the help of the enzymatic digestion 
method and have shown positive CD73, CD90 and CD105 cell surface markers, 
while CD14, CD34, DC45, CD79, HLA-DR are supposedly negative. Human 
mesenchymal stem cells as non-hematopoietic and multipotent stem cells have 
the ability to diff erentiate into mesodermal lineage (osteocytes, adipocytes, and 
chondrocytes), ectodermal (neurocytes) and endodermal lineages (hepato-
cytes) [33]. Mesenchymal stem cells have been found in the various compart-
ments of the human umbilical cord, but the cells localized perivascularly and 
especially in the Wharton’s jelly so far show the biggest possible clinical utility. 
Mesenchymal stem cells isolated from the Wharton’s jelly can be generated in 
large numbers with minimal culture avoiding changes in phenotype, have the 
least non-stem cell contaminants, their derivation is quick and easy to stand-
ardize, they are rich in stemness characteristics and have a high diff erentiation 
potential [31]. 
Mesenchymal stem cells derived from the Wharton’s jelly of the human 
umbilical cord have a good accessibility and high expansion potential. Th ere-
fore, mesenchymal stem cells found in the human umbilical cord could be 
considered a very good alternative to the bone marrow-derived mesenchymal 
stem cells and could possibly trans-diff erentiate into neurons or glial cells 
under special circumstances [37]. It is suggested that human mesenchymal 
stem cells could have antifi brotic properties with paracrine signalling as one of 
the main underlying mechanisms behind their therapeutic eff ects. Th is thera-
peutical property might possibly be valuable when treating keloids and renal 
scarring [3, 13]. Similarly experimental studies have shown the ability of the 
Wharton’s jelly-derived mesenchymal stem cells to diff erentiate into adipocyte-
like cells with high chemokine secreting properties [2]. Th e Wharton’s jelly-
derived mesenchymal stem cells closely interact with peripheral blood mono-
nuclear cells alternating tissue homeostasis, cell death, production of cytokines 
and chemokines [19]. At the same time it is also shown that in the co-culture 
model placental cells can provide a proper environment for the induction of 
human umbilical cord mesenchymal stem cells into primordial germ cells and 
reach oocyte-like cells in vitro with the expression of oocyte-like markers [4].
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Defensins as a group of antimicrobial peptides provide the fi rst line of 
defense in the innate immune response against various pathogens. Th eir role 
has been actively discussed in wound healing, angiogenesis, immunomodu-
lation, infl ammatory diseases and malignancies [12]. It has been suggested 
that the increased expression of human beta defensin 2 along with catheli-
cidin could play an important role in homing non-hematopoietic stem cells to 
damaged myocardium aft er myocardial infarction [17]. Similar antimicrobial 
peptide eff ect on hematopoietic stem cells was detected in bone marrow during 
the recovery process aft er the transplantation of hematopoietic stem progenitor 
cells [27]. Hematopoietic progenitor cell antigen CD34 is a general marker on 
progenitor cells in various cell types. Th e expression of CD34 has been found 
early in the development in tissues associated with hematopoietic and vascular 
systems, predominantly in the umbilical cord and bone marrow [29]. Cells 
positive for CD34 are possibly good agents for clinical cell transplantation and 
the source that could be explored further in regenerative medicine [28]. 
Matrix metalloproteinases belong to the family of extracellular protein-
ases with a role in developmental biology, as well as tumor cell invasion and 
metastasis. During tissue remodelling and organ development matrix metallo-
proteinases provide the rearrangement of the extracellular matrix and modu-
late signalling pathways through proteolytic interaction with multiple substrate 
molecules [18]. Th ese proteinases are able to eff ectively take part in such 
biological events as development, tissue remodelling and homeostasis only 
together with suffi  cient expressions of their tissue inhibitors [25]. Nestin is an 
intermediate fi lament protein expressed in the early stages of development and 
has been found to be expressed in neural stem cells, as well as endothelial cells, 
cancer cells and fi broblasts. It is suggested that nestin could serve as a specifi c 
marker for mesenchymal stem cells [34]. 
Mesenchymal stem cells hold an immunoregulatory capacity and are able to 
interfere with diff erent pathways of the immune response by direct cell inter-
actions or by secreting soluble factors. Such a possible molecule involved in 
the immunosuppressive eff ect of mesenchymal stem cells seems to be a trans-
forming growth factor [10]. 
Th e aim of the study was to evaluate the antimicrobial response, the pres-
ence of undiff erentiated cells and the transforming growth factor alpha, as well 
as tissue degeneration and compensatory remodelling processes in the human 
umbilical cord.
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MATERIAL AND METHODS
In this study we included seven umbilical cord tissue samples obtained during 
both premature and full term births. Th e gestational age varied from 28 to 40 
weeks. Five newborns were girls, two – boys. 
Th e umbilical cord tissue was fi xed in the Stefanini’s solution, dehydrated 
and embedded in paraffi  n. Four micrometer-thick sections were prepared and 
stained with hematoxylin and eosin [15, 30].
hBD-2 (Cat No AF2758, Lot No VJU01, obtained from goat, dilution 
1:100, R&D Systems, Germany), CD34 (code sc-19621, obtained from mouse, 
 dilution 1:100, Santa Cruz Biotechnology, Inc., USA), MMP-2 (Cat No AF902, 
Lot No DUB03, obtained from goat, dilution 1:100, R&D Systems, Germany), 
TIMP-2 (code sc-21735, obtained from mouse, dilution 1:50, Santa Cruz 
Biotechnology, Inc., USA), nestin (code ab22035, obtained from mouse, 
 dilution 1:250, Abcam, UK) and TGF-α (code ab9578, obtained from mouse, 
dilution 1:100, Abcam, UK) primary antibodies were used in biotin–strepta-
vidin immunohisto chemistry (IMH) [16].
Umbilical cord tissues were deparaffi  nized, washed in alcohol and water, 
wash buff er (Tris-buff ered saline) and microwaved in boiling EDTA buff er, 
aft erwards again washed twice in wash buff er. Tissue samples were blocked 
with normal blocking sera for 20 minutes to decrease background staining. 
All the samples were stained with primary antibodies for 1 hour, washed in 
wash buff er and then stained for 30 minutes with LSAB+LINK with biotin-
related secondary antibodies (code K1015, DakoCytomation, Denmark) and 
washed again in wash buff er. We further stained our samples for 25 minutes 
with LSAB+LINK with peroxidase-labeled streptavidin (code K0690, DakoCy-
tomation, Denmark), washed in wash buff er and processed for 10 minutes with 
DAB substrate-chromogen system (code K3468, DakoCytomation, Denmark) 
to stain positive structures brown. Samples were then rinsed in running water 
and counterstained with hematoxylin. 
Samples were examined on Leica DC 300F camera, image processing and 
the analysis was performed on Image Pro Plus 6.0 soft ware (Media Cyber-
netics, Silver Spring, Maryland, USA).
Th e intensity of immunostaining was graded semiquantitatively, as follows 
[26]: 
• few positive structures in the visual field were labeled +, 
• a moderate number of positive structures in the visual field was labeled ++, 
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• numerous positive structures in the visual field were labeled +++, 
• and an abundance of positive structures in the visual field was marked ++++.
For statistical analyses we used non-parametric statistics and the Spearman’s 
rank correlation coeffi  cient [9].
RESULTS
All the tissue samples contained preserved two umbilical arteries and one 
umbilical vein. In fi ve tissue samples we observed no visual infl ammatory or 
degenerative changes. In two specimens we found extensive distribution of 
infl ammatory cells (macrophages and lymphocytes) both in the Wharton’s jelly 
and in the walls of arteries. 
Antimicrobial response was more prominent in the Wharton’s jelly – we 
found numerous (+++) hBD-2-containing cells, while hBD-2 positive cells in 
the walls of arteries and vein varied from a moderate number (++) to abun-
dance (++++). We have to note that the distribution of hBD-2 was selective as 
in some of our tissue samples only one of two arteries demonstrated the pres-
ence of the studied factor. Th e abundance of hBD-2-containing cells was found 
in the areas of well-defi ned infl ammation (Fig. 1) (Table 1). 
Th e presence of CD34 was found in endothelium of both umbilical arteries 
and veins, as well as in extra-embryonic mesoderm. Numerous (+++) cells in 
the Wharton’s jelly contained CD34, while in the walls of blood vessels few (+) 
to a moderate number (++) of cells stained positive for CD34 (Fig. 2). 
MMP-2, TIMP-2 and nestin positive cells were found in all the tissue 
samples and varied from numerous (+++) in the walls of blood vessels to abun-
dance (++++) in the Wharton’s jelly and infl ammation region (Fig. 3–5).
Th e abundance (++++) of TGF-α-containing cells was found in the Whar-
ton’s jelly and also moderate (++) to numerous (+++) cells of blood vessels 
contained TGF-α (Fig. 6).
We found statistically signifi cant strong positive correlation between CD34 
and MMP-2 expression (the Spearman’s rank correlation coeffi  cient was 0.881 
(P value = 0.008)). No statistically signifi cant correlations were found between 
the remaining studied factors.
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Table 1. Relative amount of hBD-2, CD34, MMP-2, TIMP-2, nestin and TGF-α positive struc-
tures in umbilical cord tissue
Tissue 
sample
Clinical data Gestational 
weeks and 
gender
hBD-2 CD34 MMP-
2
TIMP-
2
Nestin TGF-α
No. 1 Premature 
spontaneous 
labour
28, F +++ +++ ++++ ++++ ++++ +++
No. 2 2nd pregnancy, 
premature 
spontaneous 
labour
30, M ++++ +++ ++++ ++++ +++ +++
No. 3 2nd pregnancy, 
premature 
operative labour
31, F +++ ++ +++ +++ ++++ +++
No. 4 2nd pregnancy, 
1st labour, 
premature 
operative labour
34, F ++++ ++++ ++++ +++ ++++ ++++
No. 5 2nd pregnancy, 
1st labour, 
operative 
labour, distress
39, F ++++ +++ ++++ ++++ +++ ++++
No. 6 1st pregnancy, 
spontaneous 
labour, maternal 
distress
40, M +++ +++ ++++ +++ ++++ +++
No. 7 3rd pregnancy, 
1st labour, op-
erative labour, 
acute maternal 
distress, intra-
natal death of 
fetus
40, F +++ ++ +++ ++++ ++++ ++++
Mean +++ +++ ++++ ++++ ++++ ++++
Abbreviations: hBD-2 – human beta defensin 2; CD34 – hematopoietic progenitor cell antigen 
CD34; MMP-2 – matrix metalloproteinase 2; TIMP-2 – tissue inhibitor of matrix metalloprotein-
ase 2; TGF-α – transforming growth factor alpha; M – male; F – female; + few positive struc-
tures in the visual field; ++ a moderate number of positive structures in the visual field; +++ 
numerous positive structures in the visual field; ++++ an abundance of positive structures in 
the visual field.
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Figure 1. Prominent antimicrobial 
response in the Wharton’s jelly – 
abundance of hBD-2-containing 
infl ammatory cells. hBD-2 IMH, ×250, 
scale bar: 5.8 μm.
Figure 2. Moderate number of cells stained 
positive for CD34 in walls of blood vessels. 
CD34 IMH, ×250, scale bar: 5.8 μm.
Figure 3. Abundance of MMP-2 positive 
cells in the Wharton’s jelly. MMP-2 IMH, 
×250, scale bar: 5.8 μm.
Figure 4. Numerous TIMP-2-containing cells 
in the Wharton’s jelly and especially in the 
infl ammation region. TIMP-2 IMH, ×250, 
scale bar: 5.8 μm.
Figure 5. Numerous nestin-containing cells 
in umbilical blood vessels. Nestin IMH, ×100, 
scale bar: 14.5 μm.
Figure 6. Abundance of TGF-α-containing 
cells in the Wharton’s jelly. TGF-α IMH, ×250, 
scale bar: 5.8 μm.
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DISCUSSION
Various types of human cells express antimicrobial peptides and they act on 
a broad spectrum of bacterial, fungal and viral agents. Th e hBD-2 obtained 
during intratracheal transplantation of human umbilical cord blood-derived 
mesenchymal stem cells in the experimental mouse model has been shown to 
primarily down-modulate infl ammation and enhance bacterial clearance in 
Escherichia coli-induced acute lung injury [32]. Another study suggests that the 
Wharton’s jelly-derived mesenchymal stem cells having a low immunogenicity 
and immunomodulatory eff ect might be related to direct cell contact and the 
inhibition of cytokine secretion by human peripheral blood lymphocytes [36]. 
In our study, we evaluated hBD-2 expression in the umbilical cord tissue and 
found that it was expressed in all the samples with the highest expression in 
infl ammatory areas. Also, the umbilical cord tissue samples obtained during 
premature spontaneous or operative labours presented more obvious hBD-2 
expression. While we did not fi nd direct correlations with the internal and 
the external factors aff ecting placenta, possibly, the factors inducing premature 
labour or surgical intervention and associated infl ammatory reaction are the 
direct regulators of the antimicrobial response.
CD34 together with nestin in the Wharton’s jelly-derived mesenchymal 
stem cells are upregulated under hypoxia. Probably in in vitro culturing these 
cells might adopt mesodermal growth kinetics [24]. At the same time another 
study reports inability to isolate CD34 from the Wharton’s jelly mucoid connec-
tive tissue or fi broblast-like cells using the fl ow cytometric analysis. Not only 
CD34 was absent, also hematopoietic lineage marker CD45 was not found [35]. 
Th e absence of hematopoietic and endothelial markers in the Wharton’s jelly-
derived mesenchymal stem cells together with the predominant expression of 
surface antigen markers CD29, CD44, CD73, CD90, CD105 and CD166 using 
fl ow cytometry, immunofl uorescence and qRT-PCR analysis has also been 
reported [1]. We found a clear upregulation of CD34 in our samples; previ-
ously the available data on CD34 fi nding has been controversial. One potential 
explanation is that general belief on CD34 negative mesenchymal stem cells 
is based on the studies using cell cultures while tissue-resident mesenchymal 
stem cells can possibly be and are CD34 positive. Th us, the negative fi nding of 
CD34 can be a direct result of cell culturing [21]. CD34 positive cells have also 
been associated with the vascular stem cells that reside within the wall of the 
blood vessel and can diff erentiate into all the cell types that constitute a fully 
functional blood vessel, including smooth muscle cells [22]. Th is suggestion 
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explains the presence of CD34-containing cells found in the walls of blood 
vessels in our tissue samples. 
We observed clear upregulation of MMP-2, TIMP-2 and nestin in our 
tissue samples. With the help of RT-PCR it is reported that the treatment with 
cerebrospinal fl uid promotes the expression of nestin [14]. Meanwhile, the 
Wharton’s jelly-derived mesenchymal stem cells can rapidly lose their thera-
peutic properties due to oxidative stress [8]. Without any targeted environ-
mental changes nestin together with other neural progenitor cell markers and 
mature neural markers has been found in the Wharton’s jelly-derived mesen-
chymal stem cells of umbilical cords from preterm and term births [23]. Th e 
ability to express nestin might result in mesenchymal cell diff erentiation into 
motor neuron-like cells and this property could be explored when targeting 
the therapy of neurodegenerative diseases [5]. Our study shows that nestin 
expression is prominent and independent of gestational age. MMP-2 and other 
proteases involved in the degradation of the extracellular matrix have been 
found upregulated in umbilical cord blood-derived and the Wharton’s jelly-
derived mesenchymal stem cells. Th eir upregulation might be a potential path 
in exploring scarless wound healing although up to date only the limited data 
obtained from experimental model is available [11]. We found statistically 
signifi cant strong positive correlation between CD34 and MMP-2 which might 
show the linkage between the hematopoietic and degenerative properties of the 
cells originating from the umbilical cord. Concomitant increase in the expres-
sion of MMP-2 and TIMP-2 has been reported in vitro in human umbilical vein 
endothelial cells aft er hypoxia [7]. Th e prominent presence of MMP-2, TIMP-2 
and nestin suggest their role and overall cells derived from the umbilical cord 
as an important source for tissue degeneration and compensatory remodelling 
processes.
We found TGF-α both in the Wharton’s jelly and the walls of blood vessels 
which is consistent with the current understanding of the role of TGF-α. Several 
studies have detected increased levels of TGF-α together with other cytokines 
in the mesenchymal stem cells derived from the umbilical cord in comparison 
with the cells derived from bone marrow suggesting their immunosuppressive 
properties [6, 20]. TGF-α seemingly is an important growth factor for extra-
embryonic tissue development. Our study was limited to TGF-α, but the overall 
immunosuppressive eff ect of human mesenchymal stem cells could be further 
explored in the treatment of various autoimmune diseases. 
Our data confi rms that the cells derived from the human umbilical cord 
provide the antimicrobial response; MMP-2, TIMP-2 and nestin are important 
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factors in providing the balance between degeneration and tissue remodel-
ling; TGF-α could be targeted for its immunosuppressive properties. While the 
study is limited to small tissue sample number, it gives essential insight into the 
properties and molecular events of cells found in the human umbilical cord.
We conclude that the human umbilical cord possesses antimicrobial activity 
and shows the presence of undiff erentiated cells. Th e striking distribution and 
the expression of MMP-2, TIMP-2 and nestin suggest their role in the very 
eff ective and extensive tissue degeneration and compensatory remodelling 
processes. TGF-α seems to be an important growth factor for extra-embryonic 
tissue development.
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